Summary Case -control studies in diverse populations around the world have reported a lower risk of breast cancer in association with higher intake of dietary fibre and complex carbohydrates. Although this has not been confirmed in prospective studies in the USA, the observations have prompted the hypothesis that prolonged use of dietary fibre supplements might reduce breast cancer risk in high-incidence populations. Several possible mechanisms of action have been suggested, all involving a reduction of bioactive oestrogen levels in the blood. The various mechanisms are not necessarily mutually exclusive. First, a high-fibre diet might reduce circulating oestrogen levels by reducing the enterohepatic recirculation of oestrogen. Second, many plants and vegetables contain isoflavones and lignans capable of conversion in the bowel into weak oestrogens that may compete with oestradiol for target binding-sites. Third, a high-fibre diet is less often associated with obesity, which tends to increase availability of the biologically active 16-alpha metabolites of oestrone. Fourth, a high-fibre diet usually has a lower content of fat and a higher content of antioxidant vitamins, which may protect against breast cancer risk. Finally, diets rich in fibre and complex carbohydrates have been shown to improve insulin sensitivity, with an associated reduction in circulating oestrogen levels. Synergism between these effects offers a possible mechanism by which a high fibre intake might suppress breast cancer growth in women.
. Indeed, the National Institutes of Health in the USA have initiated a trial to assess the effect on women's breast cancer risk of a diet with only 20% of calories derived from fat (Greenwald, 1993) .
Attempts have been made to explain the international correlation between high levels of dietary fat and breast cancer risk by relating it to blood levels of oestrogen fractions in different populations. Oestrogen levels are generally lower in Oriental women than in Western women but in the post-menopausal age group this is mainly related to differences in body mass (Bernstein and Ross, 1993) . Preand post-menopausal breast cancer may involve different risk factors, and the much greater international variation in the incidence of the post-menopausal disease has led some to emphasise a role for nutritional factors predominantly in older women (Graham et al., 1991; Kushi et al., 1992) . Only in post-menopausal women is obesity a risk marker for breast cancer, and some studies suggest that obesity may be asociated with increased 16-alpha hydroxylation of oestradiol (Schneider et al., 1983 Although some studies show a greater effect from high dietary fibre on the risk of post-menopausal breast cancer (Lubin et al., 1986; Lee et al., 1991) , others show a similar effect in both younger and older women. Studies of vegetarians have shown lower blood levels of oestradiol in both pre-and post-menopausal women (Goldin et al., 1982; Barbosa et al., 1990 ). The mechanism is uncertain, but oestrogen metabolites are excreted in the bile, and intestinal flora and enzymes convert them to oestradiol, which is then partially reabsorbed. Some types of dietary fibre can diminish reabsorption in premenopausal women, thereby reducing the circulating oestrogen level (Schultz and Howie, 1986; Rose, 1990; Adlercreutz, 1990 cauliflower) which is claimed to have anti-cancer properties (Beecher, 1994) . A derivative of this agent is reported to exert both oestrogenic and antioestrogenic effects on human mammary cancer cells in culture (Liu et al., 1994) . Thus, the protective effect of vegetables and plants may be due to factors independent of their content of fibre or antioxidant vitamins, but we still need to identify those containing agents of which the antioestrogenic effect is clearly greater than their oestrogenic effect (Goldin, 1994 ). An alternative mechanism may be through a high-fibre diet antagonising the development of insulin resistance. While a fat-rich diet may stimulate the development of insulin resistance, diets rich in fibre and complex carbohydrates have the opposite effect (Smith, 1994) . A case-control study in the Netherlands has shown insulin resistance and hyperinsulinaemia to be a risk marker for breast cancer (Bruning et al., 1992) . Stimulation of breast cancer growth may involve synergism between oestradiol and insulin-like growth factor 1 in a mitogenic effect on breast tissue (Stewart et al., 1990) . A tendency to insulin resistance is genetically determined but can be triggered by a fat-rich diet (Zimmet, 1993) . Insulin resistance is commonly associated with an elevated level of bioavailable oestrogen (Bruning et al., 1992) , and this observation has prompted the hypothesis that breast cancer may be promoted at critical times in a woman's life by the metabolic/endocrine abnormality (Stoll, 1995) .
It is claimed that raised blood insulin levels can be reduced by a diet rich in fibre and complex carbohydrate (Anderson, 1977) . In a group of 29 subjects with hyperinsulinaemia, 17 achieved normalisation of insulin levels after 3 weeks on a high-carbohydrate, high-fibre diet combined with daily exercise (Barnard et al., 1992) . Long-term high dietary fibre intake is more likely to improve insulin sensitivity (Lovejoy and Di Girolamo, 1992) and such an effect can be achieved in all age groups (Fukagawa et al., 1990) . It has been suggested that the beneficial effect of a high carbohydrate, low-fat diet is more closely related to its fibre content than to its carbohydrate content (Riccardi et al., 1984) .
Conclusion
It is possible to test the hypothesis that breast cancer growth may be suppressed by synergism between improved insulin sensitivity and a reduced level of bioavailable oestrogen. High-fibre supplements could be given in a trial of adjuvant dietary treatment following primary surgery in both pre-and post-menopausal women with early breast cancer. Any possible effect on prognosis could be correlated with observations on insulin and oestrogen levels in the serum. Such a trial would expand the observations of an adjuvant dietary fat-reduction trial in post menopausal women (Chlebowski et al., 1991) at present under way in the USA with the participation of 20 centres (DP Rose, personal communication).
Meanwhile, the available evidence of benefit from high dietary fibre suggests that breast cancer patients who wish to adopt a healthier diet might include such a measure, even if the optimal fibre constituents are still uncertain. Future research should aim to identify specific types of fat and dietary fibre for testing in intervention trials.
